DCF Advisers’s Biohaven BHVN Stock Holding History

DCF Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Sell	123,500 -28,000	-18%	-$306K	0.28%	57
2025 Q4	$1.71M	Sell	151,500 -20,000	-12%	-$248K	0.46%	53
2025 Q3	$2.57M	Buy	171,500 +115,000	+204%	+$1.67M	0.83%	35
2025 Q2	$797K	Buy	56,500 +6,000	+12%	+$107K	0.37%	59
2025 Q1	$1.21M	Buy	50,500 +14,500	+40%	+$511K	0.58%	48
2024 Q4	$1.34M	Buy	36,000 +5,000	+16%	+$233K	0.65%	46
2024 Q3	$1.55M	Sell	31,000 -20,700	-40%	-$805K	0.62%	38
2024 Q2	$1.79M	Buy	+51,700	New	+$2.04M	0.92%	31

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCF Advisers's BHVN Position: Q1 2026 in Review

DCF Advisers reduced its Biohaven (BHVN) stake by 18% in Q1 2026, selling an estimated $306K and leaving 123,500 shares worth $1.04M. The position accounts for 0.28% of the portfolio, ranked #57.

DCF Advisers first reported a position in BHVN in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.57M in Q3 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

DCF Advisers held 123,500 shares of Biohaven worth $1.04M as of Q1 2026.
DCF Advisers sold 28,000 Biohaven shares in Q1 2026, an estimated $306K.
Biohaven made up 0.28% of DCF Advisers's portfolio in Q1 2026, its #57 holding.
DCF Advisers first reported a position in Biohaven in Q2 2024 and has held it in 8 quarters since.
DCF Advisers's Biohaven position peaked at $2.57M in Q3 2025.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.